Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Intensive Glucose Control in Patients with Type 2 Diabetes - 15-Year Follow-up.

Reaven PD, Emanuele NV, Wiitala WL, Bahn GD, Reda DJ, McCarren M, Duckworth WC, Hayward RA; VADT Investigators.

N Engl J Med. 2019 Jun 6;380(23):2215-2224. doi: 10.1056/NEJMoa1806802.

PMID:
31167051
2.

Smoking cessation and outcome after ischemic stroke or TIA.

Epstein KA, Viscoli CM, Spence JD, Young LH, Inzucchi SE, Gorman M, Gerstenhaber B, Guarino PD, Dixit A, Furie KL, Kernan WN; IRIS Trial Investigators.

Neurology. 2017 Oct 17;89(16):1723-1729. doi: 10.1212/WNL.0000000000004524. Epub 2017 Sep 8.

3.

Predictors of Cognitive Decline in Older Adult Type 2 Diabetes from the Veterans Affairs Diabetes Trial.

Zimering MB, Knight J, Ge L, Bahn G; VADT Investigators.

Front Endocrinol (Lausanne). 2016 Sep 8;7:123. doi: 10.3389/fendo.2016.00123. eCollection 2016.

4.

Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage.

Qureshi AI, Palesch YY, Barsan WG, Hanley DF, Hsu CY, Martin RL, Moy CS, Silbergleit R, Steiner T, Suarez JI, Toyoda K, Wang Y, Yamamoto H, Yoon BW; ATACH-2 Trial Investigators and the Neurological Emergency Treatment Trials Network.

N Engl J Med. 2016 Sep 15;375(11):1033-43. doi: 10.1056/NEJMoa1603460. Epub 2016 Jun 8.

5.

Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.

Kernan WN, Viscoli CM, Furie KL, Young LH, Inzucchi SE, Gorman M, Guarino PD, Lovejoy AM, Peduzzi PN, Conwit R, Brass LM, Schwartz GG, Adams HP Jr, Berger L, Carolei A, Clark W, Coull B, Ford GA, Kleindorfer D, O'Leary JR, Parsons MW, Ringleb P, Sen S, Spence JD, Tanne D, Wang D, Winder TR; IRIS Trial Investigators.

N Engl J Med. 2016 Apr 7;374(14):1321-31. doi: 10.1056/NEJMoa1506930. Epub 2016 Feb 17.

6.

Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes.

Hayward RA, Reaven PD, Wiitala WL, Bahn GD, Reda DJ, Ge L, McCarren M, Duckworth WC, Emanuele NV; VADT Investigators.

N Engl J Med. 2015 Jun 4;372(23):2197-206. doi: 10.1056/NEJMoa1414266. Erratum in: N Engl J Med. 2015 Jul 9;373(2):198.

7.

Rosiglitazone treatment and cardiovascular disease in the Veterans Affairs Diabetes Trial.

Florez H, Reaven PD, Bahn G, Moritz T, Warren S, Marks J, Reda D, Duckworth W, Abraira C, Hayward R, Emanuele N; VADT Research Group.

Diabetes Obes Metab. 2015 Oct;17(10):949-55. doi: 10.1111/dom.12487. Epub 2015 Jun 17.

8.

Increased brain volume among good grade patients with intracerebral hemorrhage. Results from the Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) study.

Qureshi AI, Majidi S, Gilani WI, Palesch YY, Martin R, Novitzke J, Cruz-Flores S, Ehtisham A, Goldstein JN, Kirmani JF, Hussein HM, Suri MF, Tariq N; Antihypertensive Treatment of Acute Cerebral Hemorrhage Study Investigators.

Neurocrit Care. 2014 Jun;20(3):470-5. doi: 10.1007/s12028-013-9842-1.

PMID:
23609118
9.

Activated ERM protein plays a critical role in drug resistance of MOLT4 cells induced by CCL25.

Zhang L, Xiao R, Xiong J, Leng J, Ehtisham A, Hu Y, Ding Q, Xu H, Liu S, Wang J, Tang DG, Zhang Q.

PLoS One. 2013;8(1):e52384. doi: 10.1371/journal.pone.0052384. Epub 2013 Jan 9.

10.

Systolic blood pressure reduction and risk of acute renal injury in patients with intracerebral hemorrhage.

Qureshi AI, Palesch YY, Martin R, Novitzke J, Cruz Flores S, Ehtisham A, Goldstein JN, Kirmani JF, Hussein HM, Suri MF, Tariq N; Antihypertensive Treatment of Acute Cerebral Hemorrhage Investigators.

Am J Med. 2012 Jul;125(7):718.e1-6. doi: 10.1016/j.amjmed.2011.09.031. Epub 2012 May 4.

PMID:
22560810
11.

The duration of diabetes affects the response to intensive glucose control in type 2 subjects: the VA Diabetes Trial.

Duckworth WC, Abraira C, Moritz TE, Davis SN, Emanuele N, Goldman S, Hayward R, Huang GD, Marks JB, Reaven PD, Reda DJ, Warren SR, Zieve FJ; Investigators of the VADT.

J Diabetes Complications. 2011 Nov-Dec;25(6):355-61. doi: 10.1016/j.jdiacomp.2011.10.003. Epub 2011 Nov 4.

PMID:
22055259
12.

Association of serum glucose concentrations during acute hospitalization with hematoma expansion, perihematomal edema, and three month outcome among patients with intracerebral hemorrhage.

Qureshi AI, Palesch YY, Martin R, Novitzke J, Cruz-Flores S, Ehtisham A, Ezzeddine MA, Goldstein JN, Kirmani JF, Hussein HM, Suri MF, Tariq N, Liu Y; ATACH Investigators.

Neurocrit Care. 2011 Dec;15(3):428-35. doi: 10.1007/s12028-011-9541-8.

PMID:
21573860
13.

Levetiracetam is associated with improved cognitive outcome for patients with intracranial hemorrhage.

Taylor S, Heinrichs RJ, Janzen JM, Ehtisham A.

Neurocrit Care. 2011 Aug;15(1):80-4. doi: 10.1007/s12028-010-9341-6.

PMID:
20890680
14.

Effect of systolic blood pressure reduction on hematoma expansion, perihematomal edema, and 3-month outcome among patients with intracerebral hemorrhage: results from the antihypertensive treatment of acute cerebral hemorrhage study.

Qureshi AI, Palesch YY, Martin R, Novitzke J, Cruz-Flores S, Ehtisham A, Ezzeddine MA, Goldstein JN, Hussein HM, Suri MF, Tariq N; Antihypertensive Treatment of Acute Cerebral Hemorrhage Study Investigators.

Arch Neurol. 2010 May;67(5):570-6. doi: 10.1001/archneurol.2010.61.

15.

Antihypertensive treatment of acute cerebral hemorrhage.

Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) investigators.

Crit Care Med. 2010 Feb;38(2):637-48. doi: 10.1097/CCM.0b013e3181b9e1a5.

16.

The impact of delirium on clinical outcomes in mechanically ventilated surgical and trauma patients.

Lat I, McMillian W, Taylor S, Janzen JM, Papadopoulos S, Korth L, Ehtisham A, Nold J, Agarwal S, Azocar R, Burke P.

Crit Care Med. 2009 Jun;37(6):1898-905. doi: 10.1097/CCM.0b013e31819ffe38.

PMID:
19384221
17.

Boosting enrollment in neurology trials with Local Identification and Outreach Networks (LIONs).

Kernan WN, Viscoli CM, Demarco D, Mendes B, Shrauger K, Schindler JL, McVeety JC, Sicklick A, Moalli D, Greco P, Bravata DM, Eisen S, Resor L, Sena K, Story D, Brass LM, Furie KL, Gutmann L, Hinnau E, Gorman M, Lovejoy AM, Inzucchi SE, Young LH, Horwitz RI; IRIS Trial Investigators.

Neurology. 2009 Apr 14;72(15):1345-51. doi: 10.1212/WNL.0b013e3181a0fda3.

18.

Use of intrathecal nicardipine for aneurysmal subarachnoid hemorrhage-induced cerebral vasospasm.

Ehtisham A, Taylor S, Bayless L, Samuels OB, Klein MW, Janzen JM.

South Med J. 2009 Feb;102(2):150-3. doi: 10.1097/SMJ.0b013e31818f8ba4.

PMID:
19139684
19.

Glucose control and vascular complications in veterans with type 2 diabetes.

Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vitek ME, Henderson WG, Huang GD; VADT Investigators.

N Engl J Med. 2009 Jan 8;360(2):129-39. doi: 10.1056/NEJMoa0808431. Epub 2008 Dec 17. Erratum in: N Engl J Med. 2009 Sep 3;361(10):1028. Erratum in: N Engl J Med. 2009 Sep 3;361(10):1024-5.

20.

Placement of external ventricular drains and intracranial pressure monitors by neurointensivists.

Ehtisham A, Taylor S, Bayless L, Klein MW, Janzen JM.

Neurocrit Care. 2009;10(2):241-7. doi: 10.1007/s12028-008-9097-4.

PMID:
18449808

Supplemental Content

Loading ...
Support Center